At 1.25x book, MTG sits above RDN and ESNT but below ACT and NMIH, placing it in the middle of the mortgage insurance group. With trailing ROE near 13% annualized from quarterly figures of roughly 3.2% to 4.0%, the multiple implies the market expects sustained returns in the low-teens, which is consistent with the peer range. The valuation suggests investors are pricing in persistency-supported earnings without paying a premium for growth, which may indicate skepticism about new insurance written volumes in the current rate environment.

Underwriting profitability has never approached the breakeven line across the ten quarters shown, so the issue is trajectory rather than solvency of the underwriting book. The swing between negative and positive loss ratios, including -5.3% in Q2 2024 and 11.6% in Q1 2026, suggests reserve development is driving much of the quarterly noise rather than a steady claims trend. Investors should monitor whether the expense ratio, which has risen from 18.4% to roughly 15% to 16%, is stabilizing, as that line item determines how much of the loss variability reaches the bottom line.

ROE declined gradually while the underwriting margin remained above 70%, which suggests the denominator effect of capital return is the primary driver rather than earnings erosion. Investment income data is unavailable across the period, so the contribution of float yield to ROE cannot be separated from underwriting profit. The return profile therefore rests on underwriting strength, and a decision to hold capital idle would likely dilute ROE further.

The debt-to-equity figure is low enough that financial leverage is not a meaningful constraint on the equity story. Underwriting leverage, measured by premium-to-surplus, is not directly disclosed in the supplied data, so the more relevant capital test is PMIERs sufficiency, which warrants verification in the next filing. Investors should treat the balance sheet as a capacity for capital return rather than a source of risk, while recognizing that the buyback pace may be inconsistent with long-run reinvestment needs.

MTG's ROE is competitive with ESNT at 12.0% and RDN at 11.7%, placing it at the upper end of the cohort on a return basis. Its PEG of 0.44 is among the lowest in the group, which may indicate that the market is discounting forward earnings growth rather than underpricing current returns. The premium to RDN and discount to ACT suggest investors are weighing franchise quality against the perceived durability of legacy exposure.